Ключевые слова:
Экссудативный плеврит, злокачественные опухоли, плевральный выпот, диагностика, рак лёгкого, лимфома, аденокарцинома, видеоторакоскопия, паллиативное лечение, плевродез.Библиографические ссылки
Ault M.J., Rosen B.T., Scher J., Feinglass J., Barsuk J.H. Thoracentesis outcomes: A 12-year experience. Thorax. 2015; 70:127–132.
Alley E.W., Lopez J., Santoro A., Morosky A., Saraf S., Piperdi B., van Brummelen E. Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): Preliminary results from a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2017; 18:623–630.
Brims F.J.H., Meniawy T.M., Duffus I., de Fonseka D., Segal A., Creaney J., Maskell N., Lake R.A., de Klerk N., Nowak A.K. A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis. J. Thorac. Oncol. 2016; 11:573–582.
Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394–424.
Charalampidis C., Youroukou A., Lazaridis G., Baka S., Karavasilis V., Kioumis I., Pitsiou G., Papaiwannou A., Tsakiridis K., Katsikogiannis N., et al. Physiology of the pleural space. J. Thorac. Dis. 2015; 7:33–37.
Clive AO, Jones HE, Bhatnagar R, et al. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2016;5 CD01 0529.
Crnjac A. Kirurške možnosti zdrav-ljenja malignih plevralnih izlivov karcinoma dojke. Zdr. Vestn. 2020; 79:272–279.
Crnjac A., Sok M., Kamenik M. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma. Eur. J. Cardio Thorac. Surg. 2004; 26:432–436.
Desai N.R., Lee H.J. Diagnosis and management of malignant pleural effusions: State of the art in 2017. J. Thorac. Dis. 2017;9: S1111–S1122.
Havelock T., Teoh R., Laws D., Gleeson F. Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2020. Thorax. 2020;65: i61–i76.
Kindler H.L., Ismaila N., Armato S.G., Bueno R., Hesdorffer M., Ja-han T., Jones C.M., Miettinen M., Pass H., Rimner A., et al. Treatment of Malig-nant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Prac-tice Guideline. J. Clin. Oncol. 2018; 36:13 43–1373.
Roberts ME, Neville E, Berristford RG, et al. Management of malignant pleural effusion: British Thoracic Society pleural disease guideline 2020. Thorax. 2020;65(Suppl 2): ii32–ii40.
Scarci M, Caruana E, Bertolaccini L, et al. Current practices in the management of malignant pleural effusions: a survey among members of the European Society of Thoracic Surgeons. Interact Cardiovasc Thorac Surg 2017; 24: 414–417.
Stathopoulos G.T., Kalomenidis I. Malignant pleural effusion: Tumor-host interactions unleashed. Am. J. Respir. Crit. Care Med. 2020; 186:487–492.
Taghizadeh N, Fortin M, Tremblay A. US hospitalizations for malignant pleural effusions: data from the 2021 National Inpatient Sample. Chest 2017; 151: 845–854
Insa R, Marin M, Martin A, et al. Systematic use of universal 16S rRNA gene polymerase chain reaction (PCR) and sequencing for processing pleural effusions improves conventional culture techniques. Medicine (Baltimore) 2020; 91:103–110.
Трахтенберг А. Х., Соколов В. В., Филоненко Е. В. и др. Торакоскопическая флюоресцентная диагностика и внутриплевральная фотодинамическая терапия у онкологических больных с первичным и метастатическим плевритом Рос. онкол. журн. 2009. № 2. С. 8–12.